EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
TMPMU
MPM BioImpact is a company that builds and invests in biotech companies with innovative technologies that are developing life-saving drugs for patients.
Protego Biopharma Lands $130 Million Oversubscribed Series B Financing
Protego Biopharma Raises $130M in Series B Financing
Protego Biopharma Secures $130M Series B Funding
Protego Biopharma Secures $130M Series B Funding Led by Novartis Venture Fund